Vaccines

The Food and Drug Administration has plans to authorize the emergency use of Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) jointly-developed COVID-19 vaccine in adolescents aged between 12 to 15 years, the New York Times reported Monday. What Happened: The move means that...

The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know. Waterdrop: Working with insurance companies, Waterdrop (NYSE: WDH) seeks to...

Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits. The distribution of COVID-19 vaccines is picking up pace globally. The speed at which drugmakers...

Last week, the Dow Jones Industrial Average, S&P 500 and Nasdaq broke multiweek winning streaks with modest losses despite Friday's rally. This week's earnings will begin with Tesla (NASDAQ: TSLA) after Monday's closing. The last week of April will be a grand finale as a  third...

Ocugen Inc (NASDAQ: OCGN) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday. What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a...

Pfizer Inc (NYSE: PFE) has come to know of counterfeit versions of its COVID-19 vaccine in Poland and Mexico, the Wall Street Journal reported Wednesday. What Happened: The New York-based pharmaceutical giant tested vials recovered by authorities in both countries and confirmed they contained...

Johnson & Johnson (NYSE: JNJ) said Tuesday that the European rollout of its COVID-19 vaccine is set to continue after it got the go-ahead from the regulator on the continent. What Happened: The multinational pharmaceutical giant said in a statement that the European Medical Agency’s...

More concerns are coming out over the COVID-19 vaccine made by Johnson & Johnson (NYSE: JNJ). What Happened: Health officials in Georgia have temporarily stopped distributing the Johnson & Johnson vaccine at one site in the state's north. This is after a few people experienced...

Moderna Inc (NASDAQ: MRNA) said Monday that it had commenced testing the next generation of its COVID-19 vaccine. What Happened: The Cambridge, Massachusetts-based company said it had dosed the first volunteers with its vaccine candidate dubbed mRNA-1283. “Our investments in our mRNA platform...

Ireland is the latest country to suspend the use of the AstraZeneca vaccine temporarily.  What Happened: Many European countries now have suspended the use of AstraZeneca Plc (NASDAQ: AZN) COVID-19 vaccines after reports of blood clotting problems.    Ireland on Sunday...

British-based drugmaker AstraZeneca plc (NASDAQ: AZN) has sold its 7.7% stake in Moderna Inc. (NASDAQ: MRNA) for more than $1 billion, the Times reported Sunday. What Happened: AstraZeneca disposed of its stake in Moderna following the U.S. biotechnology company’s coronavirus vaccine...

Johnson & Johnson (NYSE: JNJ) said Wednesday that its subsidiary Janssen Biotech Inc is requesting approval from the United States Food and Drug Administration for its single-dose COVID-19 vaccine candidate. What Happened: The multinational pharma company said in a statement that...

Novavax, Inc (NASDAQ: NVAX) shares rose over 28% in regular trading and the after-hours session on Thursday. What Happened: The Maryland-based vaccine maker said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom. See...

Inoculation with Moderna Inc’s (NASDAQ: MRNA) COVID-19 vaccine in California can resume after the state said it was safe to use the batch of the vaccine that was linked to adverse events in some people, the Associated Press reported Wednesday. What Happened: California’s decision frees...

Amazon.com, Inc (NASDAQ: AMZN) wants to help the new administration in the distribution of COVID-19 vaccines, as per a letter written by Dave Clark, CEO of the e-commerce giant's worldwide consumer business, CNBC reported Wednesday. What Happened: Clark wrote to President Joe Biden that...